SVB Leerink Upgrades Tabula Rasa HealthCare to Outperform, Raises Price Target to $10

Benzinga · 05/10/2023 14:13
SVB Leerink analyst Stephanie Davis Demko upgrades Tabula Rasa HealthCare (NASDAQ:TRHC) from Market Perform to Outperform and raises the price target from $7 to $10.